Hi @rachel5239, I added your question to the Breast Cancer group as well as Transplants. Regarding Everolimus, you may be interested in this discussion:
- Has anyone been prescribed Everolimus as an immunosuppressant med? https://connect.mayoclinic.org/discussion/has-anyone-been-prescribed-everlimus-as-an-immunosuppressant-med/

"Everolimus (Afinitor) is approved to treat breast cancer. It is used in combination with exemestane in postmenopausal women with advanced hormone receptor–positive (HR+) breast cancer that is also HER2 negative (HER2-) and has not gotten better after treatment with letrozole or anastrozole." Read more https://www.cancer.gov/about-cancer/treatment/drugs/everolimus

- Here is information about financial assistance programs for everolimus from AmeriPharma https://ameripharmaspecialty.com/everolimus-copay-assistance/
- Novartis the maker of everolimus also has a patient assistance program https://pap.novartis.com/

Rachel, what type of breast cancer do you have? Is your transplant team aware of this new diagnosis?